Medicine & Life Sciences
Acquired Immunodeficiency Syndrome
7%
Africa South of the Sahara
30%
African Trypanosomiasis
18%
Albendazole
6%
Artesunate
13%
Aruba
9%
Asymptomatic Infections
9%
Azithromycin
25%
Bacterial Vaginosis
15%
Ceftriaxone
13%
Central Africa
8%
Chikungunya virus
17%
Child
17%
Chlamydia trachomatis
8%
Chrysosporium
7%
Coinfection
20%
Condoms
6%
Confidence Intervals
16%
Congo
6%
Cross-Sectional Studies
26%
Delivery of Health Care
12%
Democratic Republic of the Congo
46%
dihydroartemisinin
9%
DNA
5%
Doxycycline
17%
Eastern Africa
13%
Ebola Hemorrhagic Fever
24%
Ethiopia
100%
Female Contraceptive Devices
8%
Gambia
8%
Ghana
6%
Gonorrhea
42%
Guinea
35%
Health Facilities
13%
Health Personnel
8%
HIV-1
11%
Human Herpesvirus 2
8%
Hydroxychloroquine
5%
Immune Reconstitution Inflammatory Syndrome
14%
Incidence
19%
Income
16%
Infections
53%
Isoniazid
7%
Kenya
17%
Latent Class Analysis
6%
Leishmania donovani
8%
Lesotho
6%
liposomal amphotericin B
8%
Logistic Models
9%
Mali
6%
Mefloquine
8%
Microbial Drug Resistance
9%
Microscopy
14%
miltefosine
8%
Monkeypox virus
14%
Mozambique
16%
Multicenter Studies
7%
Mycoplasma genitalium
15%
Neglected Diseases
8%
Neisseria gonorrhoeae
56%
Nervous System Diseases
6%
Neurocysticercosis
11%
Niger
10%
Nigeria
12%
Odds Ratio
11%
Parasites
23%
Paromomycin
5%
Pharmaceutical Preparations
20%
piperaquine
10%
Placebos
7%
Plasmodium falciparum
13%
Polymerase Chain Reaction
24%
pretomanid
7%
Procalcitonin
6%
Routine Diagnostic Tests
49%
Rural Hospitals
10%
Safe Sex
5%
SARS Virus
30%
Serum
10%
Severe Acute Respiratory Syndrome
13%
Sex Workers
6%
Sexual and Gender Minorities
49%
Strongyloides stercoralis
6%
Systematic Reviews
16%
Treatment Failure
19%
Tropical Medicine
14%
Typhoid Fever
8%
Uganda
12%
Urine
6%
Viral Load
23%
Virus Diseases
11%
Viruses
10%
Visceral Leishmaniasis
84%
Western Africa
11%
Zambia
14%
Zika Virus
15%
Zika Virus Infection
9%
Zimbabwe
19%
Social Sciences
Belgian
8%
Belgium
29%
Cambodia
7%
cause
7%
Clinical Trials
9%
confidence
7%
contagious disease
28%
cross-sectional study
12%
Democratic Republic of the Congo
13%
diagnostic
16%
diagnostic test
18%
district
7%
drug
12%
East Africa
6%
Ethiopia
38%
evaluation
7%
evidence
6%
Guinea
11%
health
15%
health workers
5%
Healthcare
5%
human being
6%
illness
15%
incidence
10%
income
6%
Kenya
7%
logistics
6%
management
6%
medicine
5%
migrant
5%
morbidity
11%
mortality
9%
Mozambique
6%
Myanmar
7%
prophylaxis
34%
public health
5%
regression
8%
relapse
10%
Republic of South Africa
9%
Rwanda
6%
Sierra Leone
8%
surveillance
11%
Tanzania
5%
time
7%
travel
16%
vaccination
7%